Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Receivables (2016 - 2019)

Fresenius Medical Care AG (FMS) has 11 years of Receivables data on record, last reported at $3.9 billion in Q4 2019.

  • For Q4 2019, Receivables rose 3.56% year-over-year to $3.9 billion; the TTM value through Dec 2019 reached $3.9 billion, up 3.56%, while the annual FY2019 figure was $3.9 billion, 3.56% up from the prior year.
  • Receivables reached $3.9 billion in Q4 2019 per FMS's latest filing, up from $3.8 billion in the prior quarter.
  • Across five years, Receivables topped out at $4.6 billion in Q4 2017 and bottomed at $3.5 billion in Q4 2015.
  • Average Receivables over 5 years is $4.0 billion, with a median of $3.9 billion recorded in 2019.
  • Peak YoY movement for Receivables: rose 28.89% in 2016, then fell 17.47% in 2018.
  • A 5-year view of Receivables shows it stood at $3.5 billion in 2015, then increased by 28.89% to $4.5 billion in 2016, then rose by 1.0% to $4.6 billion in 2017, then fell by 17.47% to $3.8 billion in 2018, then increased by 3.56% to $3.9 billion in 2019.
  • Per Business Quant database, its latest 3 readings for Receivables were $3.9 billion in Q4 2019, $3.8 billion in Q4 2018, and $4.6 billion in Q4 2017.